Anti-human IFN-gamma mAb (1-D1K), unconjugated

Meng, Q., et al. (2016). Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. J Immunother.

Sahin, U., et al. (2017). Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature.

Lunemann, J. D., et al. (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. The Journal of experimental medicine.

Ott, P. A., et al. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature.

Kranz, L. M., et al. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature.